Skip to main content
OpenTrials
Completed

NCT Number: NCT07082517

Observational Study of Risk Factors for Peripheral Artery Disease in Bathroom Scale Withings Body Cardio Users

Withings Body Cardio is capable to measure PWV in the right and left lower limbs. The hypothesis of this study is a significant difference in PWV between the right and left lower limbs measured by the device may be the sign of people with more risk factors that may lead to a PAD.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

PAD - Peripheral Arterial Disease

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Withings

Issy-les-Moulineaux, Withings, 92130, France

About this study

Active users of WITHINGS Body Cardio bathroom scale will be invited to participate to the study. In case of a positive answer, the user will receive an electronic questionnaire about its health and medical history and the data recorded from the previous six months on his/her Body Cardio bathroom scale will be collected in the study.

Once consent has been given, the user's data collectedby the WITHINGS Body Cardio scales will be extracted anonymously and associated with the answers to the questionnaire.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Active and regular user of the device
  • Adult participant
  • Participant who agreed to participate in the study, after reading the study information letter
  • Participant living in France

Exclusion criteria

  • User who didn't agreed to participate to the study after reading the study information letter

Treatment and study plan

Percentage analysis

Other

Analysis the percentage of the population with risk factors that may lead to a PAD.

Primary outcomes

  1. Analysis of the distribution of risk factors for people with a high People with significant PWV difference will be compared to people with no significant PWV difference

    Time frame: 1 year

    Chi 2 test between the two population

Secondary outcomes

  1. Acceptability of the device

    Time frame: 1 year

    Amount of daily use of the device

Sponsors and collaborators

Lead sponsor

Withings

Industry

Registry information

Acronym: OBAOMI

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Jul 24, 2025
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.